Global Radiopharmaceuticals in Nuclear Medicine Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Cardinal Health
  • 5.1.1 Cardinal Health Company Profile
  • 5.1.2 Cardinal Health Business Overview
  • 5.1.3 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.2 Novartis International AG (Advanced accelerator)
  • 5.2.1 Novartis International AG (Advanced accelerator) Company Profile
  • 5.2.2 Novartis International AG (Advanced accelerator) Business Overview
  • 5.2.3 Novartis International AG (Advanced accelerator) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Novartis International AG (Advanced accelerator) Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.3 Cardinal Health, Inc.
  • 5.3.1 Cardinal Health, Inc. Company Profile
  • 5.3.2 Cardinal Health, Inc. Business Overview
  • 5.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.4 General Electric Co. (healthcare division)
  • 5.4.1 General Electric Co. (healthcare division) Company Profile
  • 5.4.2 General Electric Co. (healthcare division) Business Overview
  • 5.4.3 General Electric Co. (healthcare division) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 General Electric Co. (healthcare division) Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.5 Lantheus Medical Imaging, Inc.
  • 5.5.1 Lantheus Medical Imaging, Inc. Company Profile
  • 5.5.2 Lantheus Medical Imaging, Inc. Business Overview
  • 5.5.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.6 Fujifilm Holding Corporation
  • 5.6.1 Fujifilm Holding Corporation Company Profile
  • 5.6.2 Fujifilm Holding Corporation Business Overview
  • 5.6.3 Fujifilm Holding Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Fujifilm Holding Corporation Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.7 Bayer AG
  • 5.7.1 Bayer AG Company Profile
  • 5.7.2 Bayer AG Business Overview
  • 5.7.3 Bayer AG Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Bayer AG Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.8 Curium Pharma
  • 5.8.1 Curium Pharma Company Profile
  • 5.8.2 Curium Pharma Business Overview
  • 5.8.3 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.9 Siemens AG
  • 5.9.1 Siemens AG Company Profile
  • 5.9.2 Siemens AG Business Overview
  • 5.9.3 Siemens AG Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.9.4 Siemens AG Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.10 Jubilant Life science
  • 5.10.1 Jubilant Life science Company Profile
  • 5.10.2 Jubilant Life science Business Overview
  • 5.10.3 Jubilant Life science Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.10.4 Jubilant Life science Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.11 Medtronic, Inc.
  • 5.11.1 Medtronic, Inc. Company Profile
  • 5.11.2 Medtronic, Inc. Business Overview
  • 5.11.3 Medtronic, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.11.4 Medtronic, Inc. Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.12 Lantheus Medical Imaging
  • 5.12.1 Lantheus Medical Imaging Company Profile
  • 5.12.2 Lantheus Medical Imaging Business Overview
  • 5.12.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.12.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.13 IBA Group
  • 5.13.1 IBA Group Company Profile
  • 5.13.2 IBA Group Business Overview
  • 5.13.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.13.4 IBA Group Radiopharmaceuticals in Nuclear Medicine Products Introduction
• 5.14 Mallinckrodt plc
  • 5.14.1 Mallinckrodt plc Company Profile
  • 5.14.2 Mallinckrodt plc Business Overview
  • 5.14.3 Mallinckrodt plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.14.4 Mallinckrodt plc Radiopharmaceuticals in Nuclear Medicine Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Radiopharmaceuticals in Nuclear Medicine Price by Types (2015-2020)
• 6.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Types (2020-2025)
  • 6.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Radiopharmaceuticals in Nuclear Medicine Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Price and Growth Rate of Diagnostic
  • 6.3.2 Global Radiopharmaceuticals in Nuclear Medicine Sales, Price and Growth Rate of Therapeutic
• 6.4 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Diagnostic Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Therapeutic Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Sales and Growth Rate of Oncology (2015-2020)
  • 7.3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Sales and Growth Rate of Cardiology (2015-2020)
  • 7.3.3 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Sales and Growth Rate of Neurology (2015-2020)
  • 7.3.4 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Sales and Growth Rate of Thyroid (2015-2020)
  • 7.3.5 Global Radiopharmaceuticals in Nuclear Medicine Revenue, Sales and Growth Rate of Others (2015-2020)
• 7.4 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Oncology Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Cardiology Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 Neurology Market Revenue and Sales Forecast (2020-2025)
  • 7.4.4 Thyroid Market Revenue and Sales Forecast (2020-2025)
  • 7.4.5 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions (2015-2020)
• 8.2 Global Radiopharmaceuticals in Nuclear Medicine Market Revenue by Regions (2015-2020)
• 8.3 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Regions (2020-2025)

9 North America Radiopharmaceuticals in Nuclear Medicine Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)
• 9.3 North America Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Radiopharmaceuticals in Nuclear Medicine Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Radiopharmaceuticals in Nuclear Medicine Market Analysis by Country
  • 9.6.1 U.S. Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 9.6.2 Canada Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 9.6.3 Mexico Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate

10 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Radiopharmaceuticals in Nuclear Medicine Market Analysis by Country
  • 10.6.1 Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 10.6.2 United Kingdom Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 10.6.3 France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 10.6.4 Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 10.6.5 Spain Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 10.6.6 Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate

11 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Analysis by Country
  • 11.6.1 China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 11.6.2 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 11.6.3 South Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 11.6.4 Australia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 11.6.5 India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate

12 South America Radiopharmaceuticals in Nuclear Medicine Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)
• 12.3 South America Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Radiopharmaceuticals in Nuclear Medicine Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Radiopharmaceuticals in Nuclear Medicine Market Analysis by Country
  • 12.6.1 Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 12.6.2 Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 12.6.3 Columbia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate

13 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Analysis by Country
  • 13.6.1 UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 13.6.2 Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate
  • 13.6.3 South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate 2015-2025

Table Radiopharmaceuticals in Nuclear Medicine Key Market Segments

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) Segment by Type from 2015-2020

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Radiopharmaceuticals in Nuclear Medicine

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Cardinal Health Company Profile

Table Cardinal Health Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Cardinal Health Production and Growth Rate

Figure Cardinal Health Market Revenue ($) Market Share 2015-2020

Table Novartis International AG (Advanced accelerator) Company Profile

Table Novartis International AG (Advanced accelerator) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novartis International AG (Advanced accelerator) Production and Growth Rate

Figure Novartis International AG (Advanced accelerator) Market Revenue ($) Market Share 2015-2020

Table Cardinal Health, Inc. Company Profile

Table Cardinal Health, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Cardinal Health, Inc. Production and Growth Rate

Figure Cardinal Health, Inc. Market Revenue ($) Market Share 2015-2020

Table General Electric Co. (healthcare division) Company Profile

Table General Electric Co. (healthcare division) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure General Electric Co. (healthcare division) Production and Growth Rate

Figure General Electric Co. (healthcare division) Market Revenue ($) Market Share 2015-2020

Table Lantheus Medical Imaging, Inc. Company Profile

Table Lantheus Medical Imaging, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Lantheus Medical Imaging, Inc. Production and Growth Rate

Figure Lantheus Medical Imaging, Inc. Market Revenue ($) Market Share 2015-2020

Table Fujifilm Holding Corporation Company Profile

Table Fujifilm Holding Corporation Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Fujifilm Holding Corporation Production and Growth Rate

Figure Fujifilm Holding Corporation Market Revenue ($) Market Share 2015-2020

Table Bayer AG Company Profile

Table Bayer AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bayer AG Production and Growth Rate

Figure Bayer AG Market Revenue ($) Market Share 2015-2020

Table Curium Pharma Company Profile

Table Curium Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Curium Pharma Production and Growth Rate

Figure Curium Pharma Market Revenue ($) Market Share 2015-2020

Table Siemens AG Company Profile

Table Siemens AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Siemens AG Production and Growth Rate

Figure Siemens AG Market Revenue ($) Market Share 2015-2020

Table Jubilant Life science Company Profile

Table Jubilant Life science Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Jubilant Life science Production and Growth Rate

Figure Jubilant Life science Market Revenue ($) Market Share 2015-2020

Table Medtronic, Inc. Company Profile

Table Medtronic, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Medtronic, Inc. Production and Growth Rate

Figure Medtronic, Inc. Market Revenue ($) Market Share 2015-2020

Table Lantheus Medical Imaging Company Profile

Table Lantheus Medical Imaging Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Lantheus Medical Imaging Production and Growth Rate

Figure Lantheus Medical Imaging Market Revenue ($) Market Share 2015-2020

Table IBA Group Company Profile

Table IBA Group Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure IBA Group Production and Growth Rate

Figure IBA Group Market Revenue ($) Market Share 2015-2020

Table Mallinckrodt plc Company Profile

Table Mallinckrodt plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Mallinckrodt plc Production and Growth Rate

Figure Mallinckrodt plc Market Revenue ($) Market Share 2015-2020

Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue ($) by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Price ($) by Types (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales Share by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) by Types (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue Share by Types (2020-2025)

Figure Global Diagnostic Sales and Growth Rate (2015-2020)

Figure Global Diagnostic Price (2015-2020)

Figure Global Therapeutic Sales and Growth Rate (2015-2020)

Figure Global Therapeutic Price (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Diagnostic (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Diagnostic (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Therapeutic (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Therapeutic (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Applications (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Share by Applications (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue ($) by Applications (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Applications (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales by Applications (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales Share by Applications (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Oncology Sales and Growth Rate (2015-2020)

Figure Global Oncology Price (2015-2020)

Figure Global Cardiology Sales and Growth Rate (2015-2020)

Figure Global Cardiology Price (2015-2020)

Figure Global Neurology Sales and Growth Rate (2015-2020)

Figure Global Neurology Price (2015-2020)

Figure Global Thyroid Sales and Growth Rate (2015-2020)

Figure Global Thyroid Price (2015-2020)

Figure Global Others Sales and Growth Rate (2015-2020)

Figure Global Others Price (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Oncology (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Oncology (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Cardiology (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Cardiology (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Neurology (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Neurology (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Thyroid (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Thyroid (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast of Others (2020-2025)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales by Regions (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Regions in 2019

Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue by Regions (2015-2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Regions in 2019

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales by Regions (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales Share by Regions (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure North America Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)

Figure North America Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales (2020-2025)

Figure North America Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales (2020-2025)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure France Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales (2020-2025)

Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure South Korea Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Australia Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure India Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure South America Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure South America Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)

Figure South America Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales (2020-2025)

Figure South America Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) (2020-2025)

Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast Sales (2020-2025)

Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast Revenue ($) (2020-2025)

Figure UAE Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure Egypt Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)

Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Sales and Growth Rate (2015-2020)